Fund shareholders of Vertex Pharmaceuticals Inc
ISIN US92532F1003 · United States · LEI 54930015RAQRRZ5ZGJ91
- Fund shareholders
- 1,205
- Of which ETFs
- 310 895 other funds
- Value held
- 56.9B $ 143.7M € · 5.3B SEK
1,205 funds hold this company. This table lists the 1,185 that declare it in a regulatory filing. The other 20 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 6,744 | 3M $ | 0.18 % | as of Mar 31, 2026 ↗ |
| Transamerica Multi-Managed Balanced TRANSAMERICA FUNDS | 6,712 | 2.9M $ | 0.19 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Equal Weight U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 6,691 | 3.3M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Systematic Growth Fund VALIC Co I | 6,626 | 3.3M $ | 0.33 % | as of Feb 28, 2026 ↗ |
| Invesco V.I. Health Care Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 6,623 | 3M $ | 1.99 % | as of Mar 31, 2026 ↗ |
| Green Century Equity Fund GREEN CENTURY FUNDS | 6,561 | 2.8M $ | 0.36 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 6,525 | 2.9M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Calvert U.S. Large Cap Growth Responsible Index Fund Calvert Responsible Index Series, Inc. | 6,522 | 2.9M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| SA MFS Massachusetts Investors Trust Portfolio SUNAMERICA SERIES TRUST | 6,464 | 2.8M $ | 0.47 % | as of Apr 30, 2026 ↗ |
| Lannebo Marknad Global Lannebo Kapitalförvaltning AB | 6,463 | 27.5M SEK | 0.18 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Value ETF iShares Trust | 6,416 | 2.7M $ | 0.22 % | as of Apr 30, 2026 ↗ |
| SPP Generation 70-tal Storebrand Asset Management AS | 6,413 | 27.3M SEK | 0.08 % | as of Mar 31, 2026 ↗ |
| JNL/JPMorgan Hedged Equity Fund JNL Series Trust | 6,411 | 2.9M $ | 0.36 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Income Advantage ETF Invesco Actively Managed Exchange-Traded Fund Trust | 6,408 | 2.7M $ | 0.40 % | as of Apr 30, 2026 ↗ |
| Victory Sustainable World Fund Victory Portfolios III | 6,399 | 3.2M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| American Century U.S. Quality Growth ETF American Century ETF Trust | 6,390 | 3.2M $ | 0.14 % | as of Feb 28, 2026 ↗ |
| iShares MSCI USA Equal Weighted ETF iShares, Inc. | 6,371 | 3.2M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Columbia Integrated Large Cap Growth Fund Columbia Funds Series Trust II | 6,367 | 3.2M $ | 1.73 % | as of Feb 28, 2026 ↗ |
| SIIT DYNAMIC ASSET ALLOCATION FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 6,354 | 3.2M $ | 0.16 % | as of Feb 28, 2026 ↗ |
| Balanced Fund American Century Mutual Funds, Inc. | 6,328 | 2.7M $ | 0.30 % | as of Apr 30, 2026 ↗ |
| Transamerica S&P 500 Index VP TRANSAMERICA SERIES TRUST | 6,247 | 2.8M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Venerable US Large Cap Core Equity Fund Venerable Variable Insurance Trust | 6,239 | 2.8M $ | 0.46 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 6,231 | 2.8M $ | 0.18 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Sustainable Leaders Fund JPMorgan Trust I | 6,222 | 2.8M $ | 1.00 % | as of Mar 31, 2026 ↗ |
| SA Large Cap Value Index Portfolio SUNAMERICA SERIES TRUST | 6,212 | 2.7M $ | 0.38 % | as of Apr 30, 2026 ↗ |
| LVIP JPMorgan U.S. Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 6,173 | 2.8M $ | 0.76 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Growth ETF T. Rowe Price Exchange-Traded Funds, Inc. | 6,146 | 2.7M $ | 0.28 % | as of Mar 31, 2026 ↗ |
| U.S. Large Cap Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 6,096 | 2.6M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| Nationwide BNY Mellon Dynamic U.S. Core Fund Nationwide Mutual Funds | 6,077 | 2.6M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| Allspring Index Fund ALLSPRING FUNDS TRUST | 6,069 | 2.7M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| SIIT U.S. Equity Factor Allocation Fund SEI INSTITUTIONAL INVESTMENTS TRUST | 6,019 | 3M $ | 0.09 % | as of Feb 28, 2026 ↗ |
| PSF PGIM 50/50 Balanced Portfolio Prudential Series Fund | 6,000 | 2.7M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Transamerica Multi-Managed Balanced VP TRANSAMERICA SERIES TRUST | 5,927 | 2.6M $ | 0.21 % | as of Mar 31, 2026 ↗ |
| NVIT J.P. Morgan Equity and Options Total Return Fund Nationwide Variable Insurance Trust | 5,918 | 2.6M $ | 0.39 % | as of Mar 31, 2026 ↗ |
| Shelton Equity Income Fund SHELTON FUNDS | 5,900 | 2.9M $ | 0.28 % | as of Feb 28, 2026 ↗ |
| Victory Pioneer Fund VCT Portfolio Victory Variable Insurance Funds II | 5,891 | 2.6M $ | 1.60 % | as of Mar 31, 2026 ↗ |
| Neuberger Core Equity ETF Neuberger Berman ETF Trust | 5,887 | 2.9M $ | 0.33 % | as of Feb 28, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 5,853 | 2.6M $ | 2.50 % | as of Mar 31, 2026 ↗ |
| NIA IMPACT SOLUTIONS FUND Ultimus Managers Trust | 5,811 | 2.9M $ | 3.06 % | as of Feb 28, 2026 ↗ |
| GreenFi Redwood Fund Aspiration Funds | 5,794 | 2.6M $ | 1.91 % | as of Mar 31, 2026 ↗ |
| Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF Pacer Funds Trust | 5,779 | 2.5M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| AVIP Intech U.S. Low Volatility Portfolio AuguStar Variable Insurance Products Fund Inc | 5,722 | 2.6M $ | 0.49 % | as of Mar 31, 2026 ↗ |
| Loomis Sayles Global Growth Fund Natixis Funds Trust II | 5,659 | 2.8M $ | 2.27 % | as of Feb 28, 2026 ↗ |
| iShares U.S. Carbon Transition Readiness Aware Active ETF BlackRock ETF Trust | 5,604 | 2.4M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 5,544 | 2.4M $ | 0.12 % | as of Apr 30, 2026 ↗ |
| BNY Mellon Institutional S&P 500 Stock Index Fund BNY Mellon Investment Funds IV, Inc. | 5,534 | 2.4M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| Sofi Select 500 ETF Tidal Trust I | 5,528 | 2.7M $ | 0.48 % | as of Feb 28, 2026 ↗ |
| AVIP BlackRock Advantage Large Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 5,415 | 2.4M $ | 0.58 % | as of Mar 31, 2026 ↗ |
| SPP Generation 60-tal Storebrand Asset Management AS | 5,313 | 22.6M SEK | 0.05 % | as of Mar 31, 2026 ↗ |
| AST Aggressive Asset Allocation Portfolio Advanced Series Trust | 5,308 | 2.4M $ | 0.02 % | as of Mar 31, 2026 ↗ |
| NYLIM VP MFS Investors Trust Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 5,235 | 2.3M $ | 0.54 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 5,181 | 2.3M $ | 0.18 % | as of Mar 31, 2026 ↗ |
| ActivePassive U.S. Equity ETF Trust for Professional Managers | 5,166 | 2.6M $ | 0.11 % | as of Feb 28, 2026 ↗ |
| DWS Enhanced Core Equity Fund DEUTSCHE DWS INVESTMENT TRUST | 5,133 | 2.6M $ | 0.90 % | as of Feb 28, 2026 ↗ |
| ETC 6 Meridian Quality Growth ETF EXCHANGE TRADED CONCEPTS TRUST | 5,066 | 2.5M $ | 3.79 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Healthcare Bull 3X Shares Direxion Shares ETF Trust | 5,065 | 2.2M $ | 1.57 % | as of Apr 30, 2026 ↗ |
| VOYA RUSSELLTM LARGE CAP INDEX PORTFOLIO Voya VARIABLE PORTFOLIOS INC | 5,009 | 2.2M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| AVIP S&P 500 Index Portfolio AuguStar Variable Insurance Products Fund Inc | 4,953 | 2.2M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Allspring Large Cap Value Fund ALLSPRING FUNDS TRUST | 4,948 | 2.1M $ | 1.37 % | as of Apr 30, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 4,931 | 2.2M $ | 5.60 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar U.S. Equity ETF iShares Trust | 4,928 | 2.1M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| Davidson Multi-Cap Equity Fund Advisors Series Trust | 4,913 | 2.2M $ | 1.74 % | as of Mar 31, 2026 ↗ |
| AZL Russell 1000 Growth Index Fund Allianz Variable Insurance Products Trust | 4,908 | 2.2M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| NEOS Nasdaq-100(R) Hedged Equity Income ETF NEOS ETF Trust | 4,904 | 2.2M $ | 0.64 % | as of Mar 31, 2026 ↗ |
| SIMT LARGE CAP INDEX FUND SEI INSTITUTIONAL MANAGED TRUST | 4,876 | 2.2M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Brighthouse/Wellington Balanced Portfolio Brighthouse Funds Trust II | 4,873 | 2.2M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Capital Group U.S. Large Value ETF Capital Group Equity ETF Trust I | 4,860 | 2.4M $ | 2.68 % | as of Feb 28, 2026 ↗ |
| Capital Group U.S. Equity Fund Capital Group U.S. Equity Fund | 4,833 | 2.1M $ | 0.50 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 4,755 | 2.1M $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Skandia Nordamerika Exponering Skandia Fonder AB | 4,740 | 20.2M SEK | 0.22 % | as of Mar 31, 2026 ↗ |
| Invesco MSCI Global Climate 500 ETF Invesco Exchange-Traded Fund Trust II | 4,724 | 2M $ | 0.14 % | as of Apr 30, 2026 ↗ |
| Disciplined Value Fund American Century Quantitative Equity Funds, Inc. | 4,698 | 2.1M $ | 0.11 % | as of Mar 31, 2026 ↗ |
| Columbia Large Cap Enhanced Core Fund COLUMBIA FUNDS SERIES TRUST | 4,651 | 2.3M $ | 0.52 % | as of Feb 28, 2026 ↗ |
| Large Cap Core Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 4,634 | 2.1M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| WisdomTree U.S. LargeCap Fund WisdomTree Trust | 4,611 | 2.1M $ | 0.15 % | as of Mar 31, 2026 ↗ |
| SIMT S&P 500 Index Fund SEI INSTITUTIONAL MANAGED TRUST | 4,607 | 2.1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| MFS Core Equity Portfolio MFS VARIABLE INSURANCE TRUST II | 4,603 | 2.1M $ | 0.77 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 4,551 | 2.3M $ | 4.32 % | as of Feb 28, 2026 ↗ |
| WisdomTree U.S. Efficient Core Fund WisdomTree Trust | 4,543 | 2M $ | 0.17 % | as of Mar 31, 2026 ↗ |
| ProShares S&P 500 High Income ETF ProShares Trust | 4,528 | 2.2M $ | 0.18 % | as of Feb 28, 2026 ↗ |
| Pro-Blend Moderate Term Series Manning & Napier Fund, Inc. | 4,520 | 1.9M $ | 0.71 % | as of Apr 30, 2026 ↗ |
| Value Advantage Portfolio PACIFIC SELECT FUND | 4,452 | 2M $ | 0.44 % | as of Mar 31, 2026 ↗ |
| Principal Capital Appreciation Account Principal Variable Contract Funds, Inc | 4,449 | 2M $ | 0.85 % | as of Mar 31, 2026 ↗ |
| Xtrackers MSCI USA Selection Equity ETF DBX ETF Trust | 4,440 | 2.2M $ | 0.40 % | as of Feb 27, 2026 ↗ |
| JNL/RAFI Multi-Factor U.S. Equity Fund JNL Series Trust | 4,438 | 2M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| First Trust Large Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 4,402 | 1.9M $ | 0.15 % | as of Apr 30, 2026 ↗ |
| Guardian Integrated Research VIP Fund Guardian Variable Products Trust | 4,382 | 2M $ | 0.88 % | as of Mar 31, 2026 ↗ |
| JPMorgan Research Market Neutral Fund JPMorgan Trust I | 4,344 | 1.9M $ | 0.56 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Goldman Sachs ETF Trust | 4,298 | 2.1M $ | 0.54 % | as of Feb 28, 2026 ↗ |
| NAA LARGE CORE SERIES New Age Alpha Variable Funds Trust | 4,296 | 1.9M $ | 0.80 % | as of Mar 31, 2026 ↗ |
| NYLI U.S. Large Cap R&D Leaders ETF New York Life Investments ETF Trust | 4,293 | 1.8M $ | 0.64 % | as of Apr 30, 2026 ↗ |
| PRAXIS GROWTH INDEX FUND Praxis Mutual Funds | 4,274 | 1.9M $ | 0.28 % | as of Mar 31, 2026 ↗ |
| Aristotle Growth Equity Fund Aristotle Fund Series Trust | 4,265 | 1.9M $ | 0.87 % | as of Mar 31, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Core Portfolio Forethought Variable Insurance Trust | 4,234 | 1.9M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| ProShares Nasdaq-100 High Income ETF ProShares Trust | 4,230 | 2.1M $ | 0.58 % | as of Feb 28, 2026 ↗ |
| Victory RS Science & Technology Fund Victory Portfolios | 4,230 | 1.9M $ | 1.00 % | as of Mar 31, 2026 ↗ |
| NAA LARGE CORE FUND New Age Alpha Funds Trust | 4,228 | 1.9M $ | 0.80 % | as of Mar 31, 2026 ↗ |
| Horizon Defined Risk Fund Horizon Funds | 4,220 | 2.1M $ | 0.21 % | as of Feb 28, 2026 ↗ |
| TCW Transform 500 ETF TCW ETF Trust | 4,215 | 1.8M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| MFS Low Volatility Equity Fund MFS SERIES TRUST I | 4,187 | 2.1M $ | 0.60 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.30 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.22 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 8.06 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.44 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.27 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5.60 % | as of Mar 31, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 5.44 % | as of Feb 27, 2026 ↗ |
| ClearBridge Variable Growth Portfolio Legg Mason Partners Variable Equity Trust | 5.33 % | as of Mar 31, 2026 ↗ |
| Virtus KAR Health Sciences Fund Virtus Investment Trust | 5.09 % | as of Mar 31, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 4.90 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,048 | +76 | 123,815,099 | +2.9 % |
| 2026Q1 | 972 | -29 | 120,276,157 | +1.8 % |
| 2025Q4 | 1,001 | -22 | 118,183,576 | -3.6 % |
| 2025Q3 | 1,023 | -31 | 122,642,833 | +1.6 % |
| 2025Q2 | 1,054 | +33 | 120,769,763 | +3.2 % |
| 2025Q1 | 1,021 | -78 | 117,052,590 | +2.0 % |
| 2024Q4 | 1,099 | -59 | 114,791,743 | +0.8 % |
| 2024Q3 | 1,158 | -31 | 113,844,744 | +1.6 % |
| 2024Q2 | 1,189 | -2 | 112,003,751 | +5.6 % |
| 2024Q1 | 1,191 | -6 | 106,033,489 | -4.0 % |
| 2023Q4 | 1,197 | 110,442,131 |
Institutional managers
1,670 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Capital World Investors | 25,368,124 | 11.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 23,969,517 | 10.7B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 21,125,964 | 9.4B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 11,730,139 | 5.2B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 7,033,156 | 3.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,139,621 | 2.7B $ | as of Mar 31, 2026 |
| Capital International Investors | 5,126,077 | 2.3B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 4,003,821 | 1.8B $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 3,910,786 | 1.8B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,212,589 | 1.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,188,881 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,057,396 | 1.4B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,878,183 | 1.3B $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 2,740,059 | 1.2B $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 2,700,975 | 1.2B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 2,633,481 | 1.2B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,564,264 | 1.1B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 2,561,057 | 1.1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,417,875 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,131,527 | 951.8M $ | as of Mar 31, 2026 |
| FMR LLC | 2,020,265 | 902.1M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,955,764 | 873.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,920,871 | 857.7M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 1,888,521 | 843.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,760,122 | 786K $ | as of Mar 31, 2026 |
Declared shareholders of Vertex Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Capital World Investors | 10.10 % | 25,695,015 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 8.30 % | 21,139,169 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 7.49 % | 19,036,076 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Vertex Pharmaceuticals Inc". https://titelia.com/en/stocks/vertex-pharmaceuticals-inc-US92532F1003